search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NIGHT OWLS AT HIGHER RISK OF DYING SOONER


Night owls – people who like to stay up late and have trouble dragging themselves out of bed in the morning – have a higher risk of dying sooner than larks, people who have a natural preference for going to bed early and rising with the sun.


The study between Surrey and Northwestern Medicine in Chicago researched nearly half a million participants in the UK Biobank Study. They found owls have a 10 per cent higher risk of dying earlier than larks which equated to 50,000 people in the six-and-a-half-year period sampled.


Scientists also found owls had higher rates of diabetes, and psychological and neurological disorders.


“Night owls trying to live in a morning lark world may have health consequences for their bodies,” said Kristen Knutson, associate professor of neurology at Northwestern.


“It could be that people who are up late have an internal biological clock that doesn’t match their external environment. It could be psychological stress, eating at the wrong time for their body, not exercising enough, not sleeping enough, being awake at night by yourself, maybe drug or alcohol use. There are a whole variety of unhealthy behaviours related to being up late in the dark by yourself.”


THREE DECADES OF SURREY’S PIONEERING SLEEP RESEARCH


Using melatonin to treat sleep disorders


In 1986, Emeritus Professor Josephine Arendt’s research revealed that jet-lag can be alleviated by taking melatonin. These discoveries led to widespread use of melatonin in sleep disorders. It has also led to the development of a new drug that targets the melatonin receptor that is now on the market to treat non-24-hour sleep disorders in the blind.


Increasing alertness with blue light


In 2001, Professor Debra Skene and her team demonstrated, for the first time, that blue light at a certain wavelength (469-480 nanometres) suppresses melatonin, the hormone that promotes drowsiness and sleep. The Professor of Neuroendocrinology said: “The discovery of a novel ocular photoreceptor system in the retina and its activation by blue light has led to the development of new lighting systems to improve health.”


The impact of sleep deficiency on genes


In 2013, Professor Derk-Jan Dijk, Director of the Sleep Research Centre, and his team discovered that a lack of sleep (5.7 hours compared to 8.5 hours) affects the activity of more than 700 of our genes, including those that govern the immune system, the body’s response to stress and our natural body clock. Professor Dijk said: “Now that we have identified these effects we can use this information to investigate further the links between insufficient sleep, mistimed sleep, gene expression and overall health.”


SURREY.AC.UK


35


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52